Quantitative analysis for Cybin Inc. Common Stock (HELP) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (63.0) (grade B). 28 signals analyzed (23 differentiated alt-data).
HELP stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $5.21 | $4.88 | $4.91 |
| 2026-05-11 | $5.35 | $5.04 | $5.10 |
| 2026-05-21 | $4.66 | $4.29 | $4.60 |
| 2026-06-03 | $4.57 | $4.30 | $4.30 |
| 2026-06-15 | $4.57 | $4.21 | $4.25 |
| 2026-06-26 | $6.60 | $5.88 | $6.48 |
| 2026-07-09 | $6.73 | $6.05 | $6.63 |
| 2026-07-21 | $8.45 | $7.32 | $8.10 |
| 2026-07-31 | $8.13 | $7.80 | $7.82 |
| 2026-08-12 | $11.57 | $10.71 | $11.49 |
| 2026-08-24 | $13.24 | $11.94 | $13.02 |
| 2026-09-03 | $12.01 | $11.39 | $11.77 |
How Cybin Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | $217M | — |
| EPRX | Eupraxia Pharmaceuticals Inc. | $213M | 63.0 |
| HITI | High Tide Inc. | $212M | — |
| WHWK | Whitehawk Therapeutics Inc | $209M | — |
View all Health Care stocks by valuation and signals →
Cybin Inc. Common Stock (HELP) scores Buy (63.0), with no measured dimension below 53. Its highest are analyst consensus at 74, valuation at 72, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 74 |
| valuation | 72 |
| technicals | 53 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Cybin Inc. Common Stock (HELP): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/HELP"><img src="https://stoquant.com/badge/HELP.svg" alt="Cybin Inc. Common Stock (HELP) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.